Skip to content

Pharmaron

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2025

    Two Lab Employees Suffocate to Death After Violating Work Rules

    On June 3, 2025, two production operators at Pharmaron's scale-up laboratory in the Beijing Economic-Technological Development Area entered a flexible isolator to work in violation of rules and died of hypoxia and suffocation; in July of the same year, the company also drew attention after two female employees fought in a laboratory. The accident investigation report recommended a fine of RMB 300,000–1 million on the company and fines of 20%–50% of the previous year's income for 10 responsible persons, including CEO Lou Xiaoqiang.